Hims & Hers Health (HIMS) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Hims & Hers Health · Health Care · ref. ETF XLV · 73 calls · price $29.71
What the company does: Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
📈 Hims & Hers Health (HIMS) stock price
$29.71-45.0% over range
Oct 14, 25low $14.52 · high $62.76Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
36% recommend buying · 11 analysts
📊 JPI status :
Hims & Hers Health is part of our 2026 selection (JPI Fair + JPI Risk +), bought at the start of the year and tracked live. It no longer shows in today's ranking: its target has been reached, there is no gap left. See the 2026 selection and its performance →
🎯 HIMS price target & analyst consensus — price $29.71
The price target · all analysts combined (10 targets)
Highest target · 1 firm of 10$42+41.4%
Median target · of 10 targets$32.5+9.4%
Lowest target · 1 firm of 10$26-12.5%
Current price$29.71
Where these 10 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
880%
$30 ↔ $42
Below
220%
$26 ↔ $28
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: B of A Securities — 74% of its targets hit on this sector (109 calls tested). It aims for $32 (+7.7 %), call made on August 12, 2026, maturing on August 12, 2027 (63 d ago).
The 5 reliable analysts
$32+7.7 %
The 5 other firms
$35+18 %
How to read it: the 5 reliable firms are not filtered by optimism — 4 aim above the price, 1 below, hence their $32 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 11 ratings (last 6 months)
Strong Buy00%
Buy436%
Hold764%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 HIMS price target all
All 73 calls, one by one, with our verdict on each firm.
→ See all 73 targets, analyst by analyst💡 The best analysts on HIMS most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in HIMS? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Hims & Hers Health? The JPI assistant answers using our backtest data.
📈 Hims & Hers Health fundamentals: valuation, margins & growth › open the full page
P/E —Net margin -5.5 %Revenue growth +38.2 %Not (yet) profitable
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. -12 %
2023
Rev +65%
2024
Rev +69%
2025
Rev +59%Profit +2%
🏛️ Hims & Hers Health insider buying: who's buying and how much › open the full page
1 insider bought1 buys / 6 mo $1.2M
🔎 Detailed analyses
✅ Historical analyst reliability on HIMS
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| TD Cowen ↗ | 100% | +95.5% | 4 |
| Guggenheim ↗ | 100% | +84.5% | 4 |
| B of A Securities ↗ | 92% | +75.4% | 13 |
| Tigress Financial ↗ | 75% | +81.6% | 4 |
| Credit Suisse | 75% | +15.2% | 4 |
| Citigroup ↗ | 70% | +49.4% | 10 |
| Canaccord Genuity ↗ | 67% | +55.9% | 6 |
| Piper Sandler ↗ | 50% | +63.3% | 2 |
| Needham ↗ | 40% | +9.8% | 5 |
| SVB Leerink | 0% | -40.6% | 2 |
📊 What $1,000 invested in Hims & Hers Health would be worth › open the full page
In short — $1,000 invested in Hims & Hers Health 10 years ago would be worth $3,538 today, i.e. +20%/yr on average. Best year: 2024 (+199%), worst: 2021 (-55%). Price performance, excluding dividends.
If I'd invested $1,000 in Hims & Hers Health
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,302 | +30% |
| 3 years ago | $5,409 | +441% |
| 5 years ago | $2,375 | +137% |
Return by year (Hims & Hers Health)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +4% | $1,038 (+4%) |
| 2025 | +25% | $1,302 (+30%) |
| 2024 | +199% | $3,896 (+290%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Hims & Hers Health
Loading news…
📋 All analyst calls on HIMS
Filtered on — · ✕ show all
Truist Securities ↗
Aug 24, 26
■ Hold neutral · not a buy · 🎯$32
Price at call : $31.75 — gap to target +1%
Today : $29.71 — gap to target +8%
🎯 on HIMS : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Aug 24, 27
matures : Aug 24, 27
▲ Overweight · 🎯$35
Price at call : $31.08 — upside +13%
Today : $29.71 — upside +18%
🎯 on HIMS : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Aug 21, 27
matures : Aug 21, 27
■ Neutral neutral · not a buy · 🎯$33
Price at call : $29.97 — gap to target +10%
Today : $29.71 — gap to target +11%
🎯 on HIMS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
Deutsche Bank ↗
Aug 11, 26
■ Hold neutral · not a buy · 🎯$26
Price at call : $29.97 — gap to target -13%
Today : $29.71 — gap to target -12%
🎯 on HIMS : no call matured yet · 📊 on Health : 53.8% · +9.7% (80 calls)
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
B of A Securities ↗
Aug 11, 26
■ Neutral neutral · not a buy · 🎯$32
Price at call : $29.97 — gap to target +7%
Today : $29.71 — gap to target +8%
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
■ Hold neutral · not a buy · 🎯$30
Price at call : $29.97 — gap to target +0%
Today : $29.71 — gap to target +1%
🎯 on HIMS : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
Morgan Stanley ↗
Aug 11, 26
■ Equal-Weight neutral · not a buy · 🎯$28
Price at call : $29.97 — gap to target -7%
Today : $29.71 — gap to target -6%
🎯 on HIMS : no call matured yet · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
▲ Buy · 🎯$42
Price at call : $30.51 — upside +38%
Today : $29.71 — upside +41%
🎯 on HIMS : no call matured yet · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
See the other 65 calls, newest to oldest
Truist Securities ↗
Jul 24, 26
■ Hold neutral · not a buy · 🎯$27
Price at call : $30.24 — gap to target -11%
Today : $29.71 — gap to target -9%
🎯 on HIMS : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Jul 24, 27
matures : Jul 24, 27
■ Neutral neutral · not a buy · 🎯$35
Price at call : $28.09 — gap to target +25%
Today : $29.71 — gap to target +18%
🎯 on HIMS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Jul 23, 27
matures : Jul 23, 27
B of A Securities ↗
Jul 9, 26
■ Neutral neutral · not a buy · 🎯$37
Price at call : $35.45 — gap to target +4%
Today : $29.71 — gap to target +25%
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
Canaccord Genuity ↗
Jul 1, 26
▲ Buy · 🎯$40
Price at call : $36.8 — upside +9%
Today : $29.71 — upside +35%
🎯 on HIMS : 67% (6 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
in progress (365j)
matures : Jul 1, 27
matures : Jul 1, 27
B of A Securities ↗
Jul 1, 26
■ Neutral neutral · not a buy · 🎯$36
Price at call : $37.57 — gap to target -4%
Today : $29.71 — gap to target +21%
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Jul 1, 27
matures : Jul 1, 27
▲ Overweight · 🎯$39
Price at call : $33.54 — upside +16%
Today : $29.71 — upside +31%
🎯 on HIMS : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Jun 18, 27
matures : Jun 18, 27
B of A Securities ↗
May 26, 26
■ Neutral neutral · not a buy · 🎯$25
Price at call : $25.2 — gap to target -1%
Today : $29.71 — gap to target -16%
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : May 26, 27
matures : May 26, 27
Truist Securities ↗
May 22, 26
■ Hold neutral · not a buy · 🎯$23
Price at call : $23.85 — gap to target -4%
Today : $29.71 — gap to target -23%
🎯 on HIMS : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
B of A Securities ↗
May 19, 26
■ Neutral neutral · not a buy · 🎯$28
Price at call : $23.04 — gap to target +22%
Today : $29.71 — gap to target -6%
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : May 19, 27
matures : May 19, 27
B of A Securities ↗
May 13, 26
■ Neutral neutral · not a buy · 🎯$30
Price at call : $24.14 — gap to target +24%
Today : $29.71 — gap to target +1%
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : May 13, 27
matures : May 13, 27
■ Neutral neutral · not a buy · 🎯$28
Price at call : $24.14 — gap to target +16%
Today : $29.71 — gap to target -6%
🎯 on HIMS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
▲ Overweight · 🎯$33
Price at call : $24.14 — upside +37%
Today : $29.71 — upside +11%
🎯 on HIMS : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
■ Neutral neutral · not a buy
🎯 on HIMS : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
▲ Buy · 🎯$35
Price at call : $25.03 — upside +40%
Today : $29.71 — upside +18%
🎯 on HIMS : no call matured yet · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
▲ Overweight · 🎯$35
Price at call : $29.39 — upside +19%
Today : $29.71 — upside +18%
🎯 on HIMS : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
B of A Securities ↗
Apr 24, 26
■ Neutral neutral · not a buy · 🎯$32
Price at call : $30.56 — gap to target +5%
Today : $29.71 — gap to target +8%
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
B of A Securities ↗
Apr 16, 26
■ Neutral neutral · not a buy · 🎯$25
Price at call : $26.99 — gap to target -7%
Today : $29.71 — gap to target -16%
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Apr 16, 27
matures : Apr 16, 27
■ Hold neutral · not a buy · 🎯$23
Price at call : $18.78 — gap to target +22%
Today : $29.71 — gap to target -23%
🎯 on HIMS : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Mar 27, 27
matures : Mar 27, 27
Leerink Partners ↗
Mar 16, 26
■ Market Perform neutral · not a buy · 🎯$25
Price at call : $24.98 — gap to target +0%
Today : $29.71 — gap to target -16%
🎯 on HIMS : no call matured yet · 📊 on Health : 58.3% · +20.9% (12 calls)
in progress (365j)
matures : Mar 16, 27
matures : Mar 16, 27
▲ Overweight · 🎯$29
Price at call : $23.84 — upside +22%
Today : $29.71 — upside -2%
🎯 on HIMS : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Mar 11, 27
matures : Mar 11, 27
■ Neutral neutral · not a buy · 🎯$24
Price at call : $23.47 — gap to target +2%
Today : $29.71 — gap to target -19%
🎯 on HIMS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Mar 10, 27
matures : Mar 10, 27
Deutsche Bank ↗
Mar 10, 26
■ Hold neutral · not a buy · 🎯$28
Price at call : $23.47 — gap to target +19%
Today : $29.71 — gap to target -6%
🎯 on HIMS : no call matured yet · 📊 on Health : 53.8% · +9.7% (80 calls)
in progress (365j)
matures : Mar 10, 27
matures : Mar 10, 27
B of A Securities ↗
Mar 10, 26
■ Neutral neutral · not a buy · 🎯$23
Price at call : $23.47 — gap to target -2%
Today : $29.71 — gap to target -23%
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Mar 10, 27
matures : Mar 10, 27
▲ Buy · 🎯$30
Price at call : $23.47 — upside +28%
Today : $29.71 — upside +1%
🎯 on HIMS : no call matured yet · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Mar 9, 27
matures : Mar 9, 27
▲ Overweight · 🎯$25
Price at call : $15.6 — upside +60%
Today : $29.71 — upside -16%
🎯 on HIMS : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Morgan Stanley ↗
Feb 25, 26
■ Equal-Weight neutral · not a buy · 🎯$21
Price at call : $15.6 — gap to target +35%
Today : $29.71 — gap to target -29%
🎯 on HIMS : no call matured yet · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Leerink Partners ↗
Feb 24, 26
■ Market Perform neutral · not a buy · 🎯$17.5
Price at call : $15.82 — gap to target +11%
Today : $29.71 — gap to target -41%
🎯 on HIMS : no call matured yet · 📊 on Health : 58.3% · +20.9% (12 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
■ Neutral neutral · not a buy
🎯 on HIMS : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
▼ Sell · 🎯$13.25
Price at call : $15.82 — upside -16%
Today : $29.71 — upside -55%
🎯 on HIMS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
■ Hold neutral · not a buy · 🎯$17
Price at call : $15.82 — gap to target +7%
Today : $29.71 — gap to target -43%
🎯 on HIMS : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
Truist Securities ↗
Feb 24, 26
■ Hold neutral · not a buy · 🎯$18
Price at call : $15.82 — gap to target +14%
Today : $29.71 — gap to target -39%
🎯 on HIMS : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
Evercore ISI Group ↗
Feb 24, 26
■ In-Line neutral · not a buy · 🎯$24
Price at call : $15.82 — gap to target +52%
Today : $29.71 — gap to target -19%
🎯 on HIMS : no call matured yet · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
■ Hold neutral · not a buy · 🎯$20
Price at call : $17.24 — gap to target +16%
Today : $29.71 — gap to target -33%
🎯 on HIMS : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
▼ Sell · 🎯$16.5
Price at call : $17.24 — upside -4%
Today : $29.71 — upside -44%
🎯 on HIMS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
B of A Securities ↗
Feb 9, 26
▼ Underperform · 🎯$21
Price at call : $19.33 — upside +9%
Today : $29.71 — upside -29%
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
▲ Buy · 🎯$60
Price at call : $26.44 — upside +127%
Today : $29.71 — upside +102%
🎯 on HIMS : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Evercore ISI Group ↗
Jan 12, 26
■ In-Line neutral · not a buy · 🎯$33
Price at call : $32.34 — gap to target +2%
Today : $29.71 — gap to target +11%
🎯 on HIMS : no call matured yet · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Jan 12, 27
matures : Jan 12, 27
▲ Overweight · 🎯$48
Price at call : $37.88 — upside +27%
Today : $29.71 — upside +62%
🎯 on HIMS : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
B of A Securities ↗
Nov 4, 25
▼ Underperform · 🎯$32
Price at call : $42.79 — upside -25%
Today : $29.71 — upside +8%
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
▲ Buy · 🎯$85
Price at call : $42.79 — upside +99%
Today : $29.71 — upside +186%
🎯 on HIMS : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
■ Sector Weight neutral · not a buy
🎯 on HIMS : no call matured yet · 📊 on Health : 31.9% · -11.8% (47 calls)
in progress (365j)
matures : Oct 21, 26
matures : Oct 21, 26
Canaccord Genuity ↗
Sep 12, 25
▲ Buy · 🎯$68
Price at call : $55.5 — upside +23%
Today : $29.71 — upside +129%
Expected +23% · Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on HIMS : 67% (6 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
-48.1%
stock -48% · XLV +21%
matured Sep 12, 26
B of A Securities ↗
Apr 29, 25
▼ Underperform · 🎯$26
Price at call : $33.1 — upside -21%
Today : $29.71 — upside -12%
Expected -21% · Actual -18% · Reason (≤ −15%) : ✓ Yes
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+17.9%
stock -18% · XLV +4%
matured Apr 29, 26
B of A Securities ↗
Mar 18, 25
▼ Underperform · 🎯$22
Price at call : $31.49 — upside -30%
Today : $29.71 — upside -26%
Expected -30% · Actual -26% · Reason (≤ −15%) : ✓ Yes
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+26.5%
stock -26% · XLV +0%
matured Mar 18, 26
B of A Securities ↗
Mar 6, 25
▼ Underperform · 🎯$21
Price at call : $35.95 — upside -42%
Today : $29.71 — upside -29%
Expected -42% · Actual -38% · Reason (≤ −15%) : ✓ Yes
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+38.4%
stock -38% · XLV +3%
matured Mar 6, 26
Leerink Partners ↗
Feb 25, 25
■ Market Perform neutral · not a buy · 🎯$40
Price at call : $41.89 — gap to target -5%
Today : $29.71 — gap to target +35%
🎯 on HIMS : no call matured yet · 📊 on Health : 58.3% · +20.9% (12 calls)
in progress (365j)
matures : Feb 25, 26
matures : Feb 25, 26
B of A Securities ↗
Feb 20, 25
▼ Underperform · 🎯$21
Price at call : $66.41 — upside -68%
Today : $29.71 — upside -29%
Expected -68% · Actual -76% · Reason (≤ −15%) : ✓ Yes
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+76.5%
stock -76% · XLV +7%
matured Feb 20, 26
Canaccord Genuity ↗
Feb 19, 25
▲ Buy · 🎯$68
Price at call : $66.41 — upside +2%
Today : $29.71 — upside +129%
Expected +2% · Actual -76% · Reason (≥ +15%) : ✗ No
🎯 on HIMS : 67% (6 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
-76.5%
stock -76% · XLV +7%
matured Feb 19, 26
Canaccord Genuity ↗
Dec 2, 24
▲ Buy · 🎯$38
Price at call : $30.85 — upside +23%
Today : $29.71 — upside +28%
Expected +23% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 67% (6 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+17.7%
stock +18% · XLV +5%
matured Dec 2, 25
B of A Securities ↗
Nov 14, 24
▼ Underperform · 🎯$18
Price at call : $19.32 — upside -7%
Today : $29.71 — upside -39%
Expected -7% · Actual +84% · Reason (≤ −15%) : ✗ No
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
-84.2%
stock +84% · XLV +7%
matured Nov 14, 25
Canaccord Genuity ↗
Nov 5, 24
▲ Buy · 🎯$28
Price at call : $20.64 — upside +36%
Today : $29.71 — upside -6%
Expected +36% · Actual +112% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 67% (6 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+111.9%
stock +112% · XLV -1%
matured Nov 5, 25
B of A Securities ↗
Oct 21, 24
▲ Buy · 🎯$25
Price at call : $23.05 — upside +8%
Today : $29.71 — upside -16%
Expected +8% · Actual +114% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+114.1%
stock +114% · XLV -4%
matured Oct 21, 25
B of A Securities ↗
Oct 14, 24
▲ Buy · 🎯$23
Price at call : $22.8 — upside +1%
Today : $29.71 — upside -23%
Expected +1% · Actual +175% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+175.3%
stock +175% · XLV -7%
matured Oct 14, 25
B of A Securities ↗
Sep 13, 24
▲ Buy · 🎯$20
Price at call : $16.28 — upside +23%
Today : $29.71 — upside -33%
Expected +23% · Actual +231% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+231.4%
stock +231% · XLV -13%
matured Sep 13, 25
B of A Securities ↗
Jun 13, 24
▲ Buy · 🎯$26
Price at call : $23.75 — upside +9%
Today : $29.71 — upside -12%
Expected +9% · Actual +152% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+151.7%
stock +152% · XLV -7%
matured Jun 13, 25
B of A Securities ↗
Jun 3, 24
▲ Buy · 🎯$22
Price at call : $20.49 — upside +7%
Today : $29.71 — upside -26%
Expected +7% · Actual +167% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+167.1%
stock +167% · XLV -8%
matured Jun 3, 25
Canaccord Genuity ↗
May 22, 24
▲ Buy · 🎯$24
Price at call : $15.83 — upside +52%
Today : $29.71 — upside -19%
Expected +52% · Actual +246% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 67% (6 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+246.4%
stock +246% · XLV -10%
matured May 22, 25
Canaccord Genuity ↗
Apr 10, 24
▲ Buy · 🎯$20
Price at call : $14.55 — upside +37%
Today : $29.71 — upside -33%
Expected +37% · Actual +84% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 67% (6 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+84.3%
stock +84% · XLV -5%
matured Apr 10, 25
Leerink Partners ↗
Feb 26, 24
■ Market Perform neutral · not a buy · 🎯$10
Price at call : $10.25 — gap to target -2%
Today : $29.71 — gap to target -66%
🎯 on HIMS : no call matured yet · 📊 on Health : 58.3% · +20.9% (12 calls)
in progress (365j)
matures : Feb 25, 25
matures : Feb 25, 25
Tigress Financial ↗
Jan 5, 24
▲ Buy · 🎯$15
Price at call : $8.81 — upside +70%
Today : $29.71 — upside -50%
Expected +70% · Actual +205% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 75% (4 calls matureds) · 📊 on Health : 66.7% · +47.5% (6 calls)
+205.3%
stock +205% · XLV -1%
matured Jan 4, 25
Tigress Financial ↗
Jun 15, 23
▲ Buy · 🎯$14
Price at call : $8.65 — upside +62%
Today : $29.71 — upside -53%
Expected +62% · Actual +179% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 75% (4 calls matureds) · 📊 on Health : 66.7% · +47.5% (6 calls)
+179.2%
stock +179% · XLV +10%
matured Jun 14, 24
B of A Securities ↗
May 9, 23
▲ Buy · 🎯$15
Price at call : $10.7 — upside +40%
Today : $29.71 — upside -50%
Expected +40% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+20.8%
stock +21% · XLV +8%
matured May 8, 24
B of A Securities ↗
Feb 28, 23
▲ Buy · 🎯$13.5
Price at call : $11.27 — upside +20%
Today : $29.71 — upside -55%
Expected +20% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 92% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+18.3%
stock +18% · XLV +15%
matured Feb 28, 24
Tigress Financial ↗
Jan 12, 23
▲ Buy · 🎯$12
Price at call : $7.1 — upside +69%
Today : $29.71 — upside -60%
Expected +69% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on HIMS : 75% (4 calls matureds) · 📊 on Health : 66.7% · +47.5% (6 calls)
+20.7%
stock +21% · XLV +4%
matured Jan 12, 24
Tigress Financial ↗
Feb 8, 21
▲ Buy
Actual -79% · Reason (≥ +15%) : ✗ No
🎯 on HIMS : 75% (4 calls matureds) · 📊 on Health : 66.7% · +47.5% (6 calls)
-78.9%
stock -79% · XLV +16%
matured Feb 8, 22
Frequently asked questions
Should I buy Hims & Hers Health stock?
This isn't buy advice. For Hims & Hers Health, the analyst consensus is "Hold", with an average price target of $32.50 (+9% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on Hims & Hers Health). We show the numbers — you decide.
Is it too late to buy Hims & Hers Health? How high can it go?
The most bullish analyst target on Hims & Hers Health is $42.00 (+41% above today's price); the average is $32.50. That's the upside they see. Check how reliable those analysts have actually been on Hims & Hers Health on our site before trusting it.
Is Hims & Hers Health still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 10 analysts have a real record on Hims & Hers Health, the best hitting 100% over 4 calls. Current consensus: "Hold". Make your call on data, not noise.
Will Hims & Hers Health stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will HIMS stock recover (go back up)?
Should you invest in Hims & Hers Health? The case for and against
The arguments for and against, one by one, from the numbers: why invest in HIMS (and why hesitate).
What has Hims & Hers Health's past performance been?
Historical returns and a "how much if I had invested" calculator: HIMS performance & returns.
What is the best month to buy HIMS?
The 12 months ranked by the stock's past returns: best & worst month to buy HIMS.
Are insiders buying HIMS stock?
Executives' and large holders' buys and sells, decoded: insider buying on HIMS.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX